Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.2B 587M 514M 474M 438M 830M 56.01B 844M 5.66B 2.22B 27.59B 2.16B 94.86B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.23B 595M 521M 480M 443M 841M 56.76B 856M 5.74B 2.25B 27.96B 2.19B 96.12B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
43.12%
Yield 2024
1.64%
Yield 2025 2.18%
1 day+2.69%
1 week+3.19%
Current month+4.13%
1 month+6.15%
3 months+7.56%
6 months-1.21%
Current year-0.85%
1 week 60
Extreme 60
64.5
1 month 58.35
Extreme 58.35
64.5
Current year 53.89
Extreme 53.8857
68.51
1 year 53.89
Extreme 53.8857
79.09
3 years 51.54
Extreme 51.5429
112.91
5 years 51.54
Extreme 51.5429
112.91
10 years 51.54
Extreme 51.5429
112.91
Manager TitleAgeSince
Chief Executive Officer 45 05/09/2018
Director of Finance/CFO - 11/03/2024
Chief Tech/Sci/R&D Officer 51 01/01/2023
Director TitleAgeSince
Chairman 54 10/04/2022
Director/Board Member 45 13/09/2023
Director/Board Member 45 10/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.69%+3.19%-9.33% - 587M
-0.17%+3.45%+15.94%+86.88% 48.73B
+1.04%-3.54%+67.29%+114.44% 35.82B
-0.13%-1.14%-3.51%+41.03% 12.2B
-0.71%+4.64%+17.61%+97.65% 12.11B
+0.76%+1.75%+34.02%+123.93% 9.11B
-0.86%+1.08%+53.57%-3.92% 7.09B
+0.75%-0.82%+17.49%+44.79% 7B
+0.69%+3.96%+25.52%+231.22% 6.7B
+5.45%+1.89%-18.02%+13.55% 5.78B
Average +0.95%+0.59%+20.06%+83.28% 14.51B
Weighted average by Cap. +0.43%+0.52%+29.15%+90.35%

Financials

2024 2025
Net sales 394M 105M 91.79M 84.66M 78.19M 148M 10.01B 151M 1.01B 397M 4.93B 385M 16.95B 460M 123M 107M 98.95M 91.39M 173M 11.7B 176M 1.18B 464M 5.76B 450M 19.81B
Net income 79.85M 21.27M 18.6M 17.16M 15.85M 30.07M 2.03B 30.57M 205M 80.51M 999M 78.11M 3.43B 97.01M 25.84M 22.6M 20.85M 19.25M 36.53M 2.46B 37.15M 249M 97.81M 1.21B 94.9M 4.17B
Net Debt 42.83M 11.41M 9.98M 9.2M 8.5M 16.13M 1.09B 16.4M 110M 43.18M 536M 41.9M 1.84B 29.47M 7.85M 6.87M 6.33M 5.85M 11.1M 749M 11.29M 75.67M 29.72M 369M 28.83M 1.27B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
09/07/26 SAR 63.00 +2.69% 316,479
08/07/26 SAR 61.35 -0.16% 44,310
07/07/26 SAR 61.45 +1.07% 146,755
06/07/26 SAR 60.80 +0.25% 30,001
05/07/26 SAR 60.65 -0.66% 26,649
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
63.00SAR
Average target price
83.66SAR
Spread / Average Target
+32.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock